Ionis’ HAE Opportunity Boosted By Positive Phase II Data

Wholly Owned PKK-LRx HAE Candidate Hit All Endpoints

HAE
Positive HAE data lifts investor sentiment towards Ionis stock • Source: Shutterstock

More from Clinical Trials

More from R&D